Weill Cornell Tetrathiomolybdate Study Results Presented at AACR

Dr Sarika Jain, a 3rd year Hematology Fellow at Weill Cornell Medical College, presented data on one of the Breast Center’s studies at the recent American  Association for Cancer Research (AACR) meeting.

The study presented was a Phase 2 trial of Tetrathiomolybdate in women with breast cancer at high risk of relapsing. The purpose of this study was to try to keep breast cancer cells in a dormant state by depleting copper, an essential component to helping these cells come out of dormancy.

The study data shows that the researchers were able to copper deplete patients safely with few side effects, and they were able to drive down the cells we believe are critical to facilitating metastases. Click here to read the abstract of the presentation.

Leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s